KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$40.77
+0.63 (+1.57%)
As of Feb 8, 2:10 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 63.94M 59.81M 50.24M
Net Income 4.93M 5.37M 4.75M
EPS
Profit Margin 7.7% 9.0% 9.5%
Rev Growth -3.7% +13.1% -4.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 25.45M 32.14M 29.26M
Total Equity 72.46M 76.20M 84.12M
D/E Ratio 0.35 0.42 0.35
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.23M 8.28M 7.47M
Free Cash Flow 3.70M 3.50M 3.36M